SOCS3 and B-cell chronic lymphocytic leukemia: CLL cells were treated with 17-DMAG for 8 hours (the earliest time point of SOCS3 induction without any evidence of cell death), followed by stimulation with recombinant human IL-6 (rhIL-6).